SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of earliest event reported: November 25, 2003
Select Medical Corporation
(Exact name of registrant as specified in charter)
Delaware (State of Incorporation) |
000-32499 (Commission File Number) |
23-2872718 (I.R.S. Employer Identification No.) |
4716 Old Gettysburg Road, P.O. Box 2034, Mechanicsburg, PA | 17055 | |
(Address of Principal Executive Offices) | (Zip Code) |
(717) 972-1100 | ||
(Registrants telephone number, including area code) |
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits. | ||||||||
Item 9. Regulation FD Disclosure. | ||||||||
SIGNATURE | ||||||||
EXHIBIT INDEX | ||||||||
PRESS RELEASE DATED NOVEMBER 25, 2003 |
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
99.1 Select Medical Corporation press release, dated November 25, 2003.
Item 9. Regulation FD Disclosure.
On November 25, 2003, Select Medical Corporation issued a press release announcing that its Board of Directors has declared an initial quarterly cash dividend of $0.06 per share. After giving effect to the two-for-one stock split announced on November 13, 2003, Selects quarterly cash dividend will amount to $0.03 per share. A copy of the press release is attached as Exhibit 99.1 to this report.
The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 9 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934 (the Exchange Act) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
SELECT MEDICAL CORPORATION | ||||
Date: November 26, 2003 | By: | /s/ Michael E. Tarvin | ||
Michael E. Tarvin Senior Vice President, General Counsel and Secretary |
EXHIBIT INDEX
Exhibit No. | Description | |
99.1 | Select Medical Corporation press release, dated November 25, 2003. |